Disability News and Research

RSS

Novartis new MS treatment receives Notice of Compliance in Canada

Novartis Pharmaceuticals Canada Inc. announced today that its new MS treatment, Gilenya, has received Notice of Compliance in Canada.

10 Mar 2011

Preliminary phase I trial results show safety of bone marrow stem cells in children with TBI

Stem cells derived from a patient's own bone marrow were safely used in pediatric patients with traumatic brain injury, according to results of a Phase I clinical trial at The University of Texas Health Science Center at Houston.

10 Mar 2011

Researcher launches new DBS clinical trial to pinpoint brain activity in depressed people

A top medical researcher at Barrow Neurological Institute at St. Joseph's Hospital in Phoenix, Arizona, has launched a clinical trial to pinpoint brain activity in depressed people by using scientifically designed sad and heartrending photos and music.

10 Mar 2011

Vascular disorder of the brain most frequently misdiagnosed as multiple sclerosis

A devastating vascular disorder of the brain called CADASIL, which strikes young adults and leads to early dementia, often is misdiagnosed as multiple sclerosis, Loyola University Health System researchers report.

10 Mar 2011

Economic benefits of enabling people to age at home

There are a number of studies that look at the economics of technologies to enable people to age at home rather than in some other kind of accommodation. In 2010, CSES contributed an economic analysis for the ATSE report written by Greg Tegart drawing in part on these studies and using Australian data on demographic trends and healthcare costs.

9 Mar 2011

The American Journal of Medicine focuses on the continuing healthcare reform debate

As the debate about healthcare in the United States rages, four insightful articles in the March 2011 issue of The American Journal of Medicine strive to add reasoned arguments and empirical research findings to the dialog.

9 Mar 2011

Parkinson's disease medication turns on critical gene, protects brain cells

In a major breakthrough in the battle against Parkinson's disease, researchers at the University of Colorado School of Medicine have discovered a drug that stops the progression of the degenerative illness in mice and is now being tested in humans.

9 Mar 2011

Brain implant surgery can improve life for people with cervical dystonia

Implanting electrodes into a pea-sized part of the brain can dramatically improve life for people with severe cervical dystonia - a rare but extremely debilitating condition that causes painful, twisting neck muscle spasms - according to the results of a pilot study led by Jill Ostrem, MD and Philip Starr, MD PhD at the University of California, San Francisco.

9 Mar 2011

Novartis QAB149 receives FDA Pulmonary-Allergy Advisory Committee approval for COPD

An advisory committee recommended today that the Food and Drug Administration (FDA) approve QAB149 (indacaterol) 75 mcg in the US as a once-daily long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

9 Mar 2011

Smart technology for healthy longevity

A national policy is required for the research, demonstration, commercialisation and wide-scale deployment of smart technology for ageing-in-place to ensure: a healthy, safe, secure and fulfilling future for the increasing aged population in Australia by enabling them to remain at home longer, by easing the strain on the national healthcare system and providing cost effective solutions to meet the needs of the growing number of elderly Australians.

9 Mar 2011

$100 million in grants for medical research announced

More than $100 million in grants was announced this Tuesday for an ambitious research project that will try to find what makes cancer so hard to beat. This project received $21.3 million from the National Health and Medical Research Council grants.

8 Mar 2011

Conflicts in medical management of hemophilia

Hemophilia is a medical disorder that is part of our genetic load as humans. It will never disappear. Therefore, the only way to live with it is to receive adequate medical management. Its effects on those males who have inherited the disorder that affects their blood clotting without treatment includes recurrent hemorrhages (bleeds) into joints as well as internal bleeding. The bleeds are painful, resulting in disuse, disability and crippling. The first signs usually appear in early childhood. A child who suffers a mouth bleed can slowly lose enough blood to result in death.

8 Mar 2011

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.

8 Mar 2011

Prevalence of bipolar disorder

Bipolar disorder is a psychiatric disorder that swings between depression and mania. It strikes early and can cause lifelong disability. Reports show that it is chronically undertreated in many low-income countries.

7 Mar 2011

Aerie Pharmaceuticals closes $30 million Series B financing

Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $30 million Series B financing.

7 Mar 2011

Anthem Life sponsors USABA to host Winter Ski Festival for visually impaired athletes

Sponsored by Anthem Life Insurance Company, The United States Association of Blind Athletes is pleased to host the second annual Colorado Winter Ski Festival in Breckenridge, CO, from Friday, March 11 through Monday, March 14.

5 Mar 2011

OHSU receives NTI grant to study TEG for blood-clot prevention in obese trauma patients

Martin Schreiber, M.D., of Oregon Health & Science University, received a research grant worth nearly $700,000 from the National Trauma Institute to study a method that could more accurately determine how much blood-clot prevention medication to give critically ill or obese trauma patients.

5 Mar 2011

Disability News and Research

Novartis new MS treatment receives Notice of Compliance in Canada

Preliminary phase I trial results show safety of bone marrow stem cells in children with TBI

Researcher launches new DBS clinical trial to pinpoint brain activity in depressed people

Vascular disorder of the brain most frequently misdiagnosed as multiple sclerosis

Economic benefits of enabling people to age at home

The American Journal of Medicine focuses on the continuing healthcare reform debate

Parkinson's disease medication turns on critical gene, protects brain cells

Brain implant surgery can improve life for people with cervical dystonia

Novartis QAB149 receives FDA Pulmonary-Allergy Advisory Committee approval for COPD

Smart technology for healthy longevity

$100 million in grants for medical research announced

Conflicts in medical management of hemophilia

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

Prevalence of bipolar disorder

Aerie Pharmaceuticals closes $30 million Series B financing

Anthem Life sponsors USABA to host Winter Ski Festival for visually impaired athletes

OHSU receives NTI grant to study TEG for blood-clot prevention in obese trauma patients

Alcohol, marijuana and methamphetamines are common abuse substances

AAOS releases clinical practice guideline to treat rotator cuff tears

CAS is an economically attractive alternative to endarterectomy for stroke patients

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News